1887

oa South African Family Practice - Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension? : review

Volume 57, Issue 3
  • ISSN : 2078-6190

 

Abstract

The renin-angiotensin system (RAS) and angiotensin II, in particular, play a central role and have been implicated in the spectrum of cardiovascular disease (CVD), beginning with hypertension, diabetes mellitus, atherosclerosis, myocardial infarction (MI), strokes and heart failure.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mp_safp/57/3/EJC173165
2015-05-01
2017-01-23

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error